Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × lestaurtinib × Clear all

NCT00081601 2012-08-24

Study of CEP-701 in Treatment of Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms